• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Cardiol . Incidence and predictors of cardiac arrhythmias in patients with COVID-19 induced ARDS

tetano

Editor, Senior Moderator
J Cardiol


. 2022 May 16;S0914-5087(22)00101-0.
doi: 10.1016/j.jjcc.2022.04.010. Online ahead of print.
Incidence and predictors of cardiac arrhythmias in patients with COVID-19 induced ARDS


Philipp Niehues[SUP] 1 [/SUP], Felix K Wegner[SUP] 2 [/SUP], Julian Wolfes[SUP] 1 [/SUP], Kevin Willy[SUP] 1 [/SUP], Christian Ellermann[SUP] 1 [/SUP], Richard Vollenberg[SUP] 3 [/SUP], Holger Reinecke[SUP] 4 [/SUP], Felix Rosenow[SUP] 4 [/SUP], Johannes Lepper[SUP] 4 [/SUP], Jan Sackarnd[SUP] 4 [/SUP], Lars Eckardt[SUP] 1 [/SUP]



Affiliations

Abstract

Introduction: Recent studies suggest cardiac involvement with an increased incidence of arrhythmias in the setting of coronavirus disease 2019 (COVID-19). The aim of this study was to evaluate the risk of potentially lethal arrhythmias and atrial fibrillation in patients with COVID-19-induced acute respiratory distress syndrome (ARDS) and to elicit possible predictors of arrhythmia occurrence.
Methods and results: A total of 107 patients (82 male, mean age 60 ± 12 years, median body mass index 28 kg/m[SUP]2[/SUP]) treated for COVID-19-induced ARDS in a large tertiary university hospital intensive care unit between March 2020 and February 2021 were retrospectively analyzed. Eighty-four patients (79%) had at least moderate ARDS, 88 patients (83%) were mechanically ventilated, 35 patients (33%) received vvECMO. Forty-three patients (40%) died during their hospital stay. Twelve patients (11%) showed potentially lethal arrhythmias (six ventricular tachycardia, six significant bradycardia). Atrial fibrillation occurred in 27 patients (25%). In a multivariate logistic regression analysis, duration of hospitalization was associated with the occurrence of potentially lethal arrhythmias (p = 0.006). There was no association between possible predictive factors and the occurrence of atrial fibrillation. Invasive ventilation, antipsychotics, and the QT[SUB]c[/SUB] interval were independently associated with acute in-hospital mortality, but this was not arrhythmia-driven as there was no association between the occurrence of arrhythmias and mortality.
Conclusion: In this relatively young population with COVID-19-induced ARDS, the incidence of potentially lethal arrhythmias was low. While overall mortality was high in these severely affected patients, cardiac involvement and arrhythmia occurrence was not a significant driver of mortality.

Keywords: Acute respiratory distress syndrome; Arrhythmia; Atrioventricular block; Coronavirus disease 2019; Ventricular tachycardia.
 
Back
Top Bottom